PCV42 - A PHARMACOECONOMIC ANALYSIS OF THE USE OF APIXABAN FOR THE PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN RUSSIAN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.589
https://www.valueinhealthjournal.com/article/S1098-3015(18)33889-0/fulltext
Section Title :
Section Order :
2480
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33889-0&doi=10.1016/j.jval.2018.09.589